Edward M. Kennedy Health Clinic Clinic/Center - Dental Medicare: Medicare Enrolled Practice Location: 925 2nd Ave, Monte Vista, CO 81144 Phone: 719-852-2512 Fax: 719-852-3923 |
Richard D. Santi, D.d.s., P.c. Dentist Medicare: Not Enrolled in Medicare Practice Location: 10 Rupert St, Monte Vista, CO 81144 Phone: 719-852-2552 Fax: 719-852-3742 |
News Archive
"While international attention focuses on Burma, [also known as Myanmar,] a health crisis in the country looms large," Joe Billiveau, operations manager of Medecins Sans Frontieres' (MSF) operational center in Amsterdam, writes in this opinion piece in Bangkok's Nation.
New research has determined that patients in the U.S. with hepatitis C virus (HCV) are twice as likely to not have health insurance coverage compared with those without the disease. In fact researchers found only a third of HCV infected Americans have access to antiviral therapy; the remaining are either uninsured or not candidates for therapy due to treatment contraindications. Details of this study are published in the March issue of Hepatology, a peer-reviewed journal of the American Association for the Study of Liver Diseases (AASLD).
Quanterix Corporation, the single molecule diagnostics company focused on developing and commercializing high sensitivity tests, announced the publication of a breakthrough study of the company's proprietary technology that demonstrates an unprecedented sensitivity for measuring a biomarker for prostate cancer recurrence.
With many local and national governments currently debating proposals to raise alcohol taxes, a timely new study published online in the February edition of Addiction journal finds that the more alcoholic beverages cost, the less likely people are to drink.
Ipsen today announced top line results of GuidAge®, the longest (5 years) and largest (2,854 subjects) European study in the prevention of Alzheimer's Dementia (AD). This trial was conducted according to the most stringent international standards. The aim of this study was to assess the efficacy of a 5-year treatment with EGb 761® in the prevention of Alzheimer's Dementia in a population of elderly aged 70 or more, with memory complaint spontaneously expressed to their family physician and who lived at home at the inclusion in the study.
› Verified 1 days ago